from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3757c/proW

LFCtreatmentdescriptionclass of inhibitor

-0.827

Amikacinug/mL Amikacintranslation

-1.602

Cap5-10ug/mL Capreomycintranslation

-0.961

Rox10-50 ug/mL Roxithromycintranslation

-0.386

SM2-5 ug/mL Streptomycintranslation

-0.503

Tet5-10 ug/mL Tetracyclinetranslation

0.270

Rif0.2-5ug/mL Rifampicintranscription

-0.933

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.137

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.566

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.010

CPZ10-50 ug/mL Chlorpromazinerespiration

1.689

Clofazimine10-13 ug/mL Clofaziminerespiration

0.207

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.068

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.293

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.530

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.114

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.123

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.116

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.185

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.413

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.056

KCN5-20 ug/mL Potassium cyaniderespiration

-0.220

NaN30.2-2 mM Sodium aziderespiration

-0.109

Nigericin50 uM Nigericinrespiration

0.419

TRC10-150 ug/mL Triclosanrespiration

2.201

TRZ10-25 ug/mL Thioridazinerespiration

0.026

Valinomycin0.5-10 uM Valinomycinrespiration

-0.967

ZnSO42 mM ZnSO4respiration

0.799

menadione6-10 ug/mL Menadionerespiration

-0.207

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.121

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.587

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.102

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.898

NRP_1Non-replicating persistence stage 1dosRassociated

-0.332

Amp0.2mg/mL AmpicillincellWall

0.482

Cephalexin20-100 ug/mL CephalexincellWall

-0.568

Cerulenin0.32-5 ug/mL CerulenincellWall

0.183

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.171

EMB10-20 ug/mL EthambutolcellWall

-0.471

Eta12-40 ug/mL EthionamidecellWall

-0.347

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.447

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.253

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.015

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.689

BZA0.12 mg/mL BenzamidearomaticAmides

-0.479

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.362

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.238

H2O24 mM hydrogen peroxideDNAdamaging

-0.936

Levo10 ug/mL LevofloxacinDNAdamaging

-0.621

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.246

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.045

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.265

UVUV-irradiationDNAdamaging

1.762

ARP41-4 ug/mL Antitubercular compound ARP4?

0.006

Antimycin12.5-50 ug/mL Antimycin A?

0.216

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.029

PA_110-50 ug/mL Antitubercular compound PA-1?

0.093

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.303

PA8240.2-2 ug/mL PA-824?

0.777

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.667

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.521

Verapamil50 uM Verapamil?

0.541

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.185

methoxatin10-20 ug/mL Methoxatin?